Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kapp

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|January 7, 2012
Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Immunology|September 25, 2013
Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Immunology|October 18, 2013
Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effectsShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Oncology|May 6, 2014
Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Current Opinion in Infectious Diseases|May 16, 2017
Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic optionsShigeo Fuji, Hermann Einsele, Markus Kapp
Blood Cells, Molecules & Diseases|September 14, 2007
CMV-specific T cell therapyHermann Einsele, Markus Kapp, Götz Ulrich Grigoleit
Virulence|July 8, 2016
Immunotherapy for opportunistic infections: Current status and future perspectivesShigeo Fuji, Jürgen Löffler, Hermann Einsele, et al.
Current Opinion in Immunology|October 6, 2009
Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised hostGiuseppina Li Pira, Markus Kapp, Fabrizio Manca, et al.
Current Opinion in Hematology|July 10, 2009
Cellular therapy to control tumor progressionMarkus Kapp, Leo Rasche, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2015
Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant RecipientsShigeo Fuji, Hermann Einsele, Bipin N Savani, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|January 7, 2012
Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Immunology|September 25, 2013
Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Immunology|October 18, 2013
Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effectsShigeo Fuji, Markus Kapp, Hermann Einsele
Frontiers in Oncology|May 6, 2014
Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationShigeo Fuji, Markus Kapp, Hermann Einsele
Current Opinion in Infectious Diseases|May 16, 2017
Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic optionsShigeo Fuji, Hermann Einsele, Markus Kapp
Blood Cells, Molecules & Diseases|September 14, 2007
CMV-specific T cell therapyHermann Einsele, Markus Kapp, Götz Ulrich Grigoleit
Virulence|July 8, 2016
Immunotherapy for opportunistic infections: Current status and future perspectivesShigeo Fuji, Jürgen Löffler, Hermann Einsele, et al.
Current Opinion in Immunology|October 6, 2009
Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised hostGiuseppina Li Pira, Markus Kapp, Fabrizio Manca, et al.
Current Opinion in Hematology|July 10, 2009
Cellular therapy to control tumor progressionMarkus Kapp, Leo Rasche, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2015
Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant RecipientsShigeo Fuji, Hermann Einsele, Bipin N Savani, et al.
Pageof 3